These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


134 related items for PubMed ID: 3012922

  • 1. New and prospective developments in antifungal drugs.
    Cauwenbergh G.
    Acta Derm Venereol Suppl (Stockh); 1986; 121():147-53. PubMed ID: 3012922
    [Abstract] [Full Text] [Related]

  • 2. [New antifungal agents in the treatment of superficial dermatomycoses].
    Degreef H.
    Ann Dermatol Venereol; 1993; 120(1):21-31. PubMed ID: 8393313
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Allylamines: topical and oral treatment of dermatomycoses with a new class of antifungal agents.
    Ganzinger U, Stutz A, Petranyi G, Stephen A.
    Acta Derm Venereol Suppl (Stockh); 1986; 121():155-60. PubMed ID: 3459341
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Topical pharmacology of imidazole antifungals.
    Holt RJ.
    J Cutan Pathol; 1976; 3(1):45-59. PubMed ID: 945306
    [Abstract] [Full Text] [Related]

  • 8. Athlete's foot.
    Crawford F.
    Clin Evid; 2005 Dec; (14):2000-5. PubMed ID: 16620478
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The antifungal imidazoles: clotrimazole and miconazole.
    Milne LJ.
    Scott Med J; 1978 Apr; 23(2):149-52. PubMed ID: 644298
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Double blind, randomized in vivo investigations comparing the antifungals clotrimazole, tolnaftate and naftifine (author's transl)].
    Hantschke D, Reichenberger M.
    Mykosen; 1980 Dec; 23(12):657-68. PubMed ID: 7012610
    [No Abstract] [Full Text] [Related]

  • 15. Biochemical basis for the activity and selectivity of oral antifungal drugs.
    Vanden Bossche H, Marichal P, Gorrens J, Coene MC.
    Br J Clin Pract Suppl; 1990 Sep; 71():41-6. PubMed ID: 2091733
    [Abstract] [Full Text] [Related]

  • 16. Optimizing topical antifungal therapy for superficial cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis.
    Del Rosso JQ, Kircik LH.
    J Drugs Dermatol; 2013 Nov; 12(11 Suppl):s165-71. PubMed ID: 24196340
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antimycotic agents in oral candidosis: an overview: 2. Treatment of oral candidosis.
    Ellepola AN, Samaranayake LP.
    Dent Update; 2000 May; 27(4):165-70, 172-4. PubMed ID: 11218451
    [Abstract] [Full Text] [Related]

  • 19. Naftifine versus miconazole/hydrocortisone in inflammatory dermatophyte infections.
    Nada M, Hanafi S, al-Omari H, Mokhtar M, el-Shamy S, Mühlbacher J.
    Int J Dermatol; 1994 Aug; 33(8):570-2. PubMed ID: 7960355
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.